🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Clofarabine (injection) is approved by the Food and Drug Administration (FD...
Status
Completed
Location
Mary Crowley Medical Research Center
Start Date
2003-10
Trial ID
NCT00125827
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as carboplatin, work in differe...
Status
Terminated
Location
Purchase Cancer Group - Paducah
Start Date
2007-11
Trial ID
NCT00544648
Treatments Being Tested
The purpose of this Phase I study is to test the safety of different doses ...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up)
Start Date
2015-05
Trial ID
NCT02414269
Treatments Being Tested
This is a multinational (China and Korea), multicenter, randomized, double-...
Status
Completed
Location
Peking University People's Hospital
Start Date
2023-02-06
Trial ID
NCT05667623
Treatments Being Tested
To characterize the pharmacokinetic profile of pegylated liposomal doxorubi...
Status
Completed
Location
Adium S.A.
Start Date
2023-02-13
Trial ID
NCT07648940
Post-authorization, observational, multicenter and prospective study in pat...
Status
Completed
Location
Complejo Hospitalario Universitario de Santiago
Start Date
2014-07-02
Trial ID
NCT04383288
The investigators hypothesize that the combination of Gemzar®, Abraxane® an...
Status
Completed
Location
University of Miami
Start Date
2007-06
Trial ID
NCT00503906
Treatments Being Tested
An Open-label, Phase I Dose Escalation and Phase 2 Dose Expansion Study to ...
Status
Recruiting
Location
Cedars Sinai Medical Center
Start Date
2024-08-14
Trial ID
NCT06526819
Treatments Being Tested
To test a new agent, LBH589, in combination with glucocorticoids as initial...
Status
Completed
Location
H Lee Moffitt Cancer Center and Research Institute
Start Date
2010-04
Trial ID
NCT01111526
Treatments Being Tested
Phase II, Open Label, Randomized, Biomarker Study of Immune-mediated Mechan...
Status
Unknown
Location
UO di Oncologia Ematologia, Azienda Ospedaliero Universitaria di Ferrara
Start Date
2016-11-29
Trial ID
NCT03144947
Treatments Being Tested